Arrowgrass Capital Partners (US)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-19,325	Closed	-$1.55M	–	26
2019 Q3	$1.55M	Sell	19,325 -4,636	-19%	-$373K	0.12%	56
2019 Q2	$1.74M	Buy	23,961 +8,931	+59%	+$648K	0.04%	171
2019 Q1	$1.41M	Buy	+15,030	New	+$1.41M	0.04%	156